Amylyx Pharmaceuticals (AMLX) Institutional Ownership

$4.05 +0.09 (+2.27%)

(As of 12/20/2024 05:31 PM ET)

Current Institutional Ownership Percentage: 95.84%
Number of Institutional Buyers (last 12 months): 46
Total Institutional Inflows (last 12 months): $55.25M

Number of Institutional Sellers (last 12 months): 22
Total Institutional Outflows (last 12 months): $47.96M

Get AMLX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Amylyx Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

AMLX Institutional Buying and Selling by Quarter

Ad DTI

Why I'm telling friends to avoid gold stocks

Back in November, gold made a tiny move of 1.6%. But according to my backtesting by using a special type of gold trade, I would have seen a 141% gain in just a week. It happened again in March. Gold nudged up 1.2%. This time? A 104% overnight gain. And in June? A 1% gold move turned into a 74% gain in two weeks. Granted, there would have been smaller wins and those that did not work out, but you see, there's a reason I'm telling all my friends to hold off from buying gold or regular gold stocks right now. There's a more lucrative way to play the gold market as we enter a new breakout period. It's all about catching what I call "Acceleration Cycles."

And if you’d like to get your hands on this, here you go, the complete breakdown.

Amylyx Pharmaceuticals Major Shareholders & Ownership History

Export to Excel

Reporting Date	Major Shareholder Name	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/19/2024	Barclays PLC	84,572	$274K	0.0%	+91.1%	0.123%
11/16/2024	Geode Capital Management LLC	551,039	$1.79M	0.0%	+17.5%	0.804%
11/15/2024	Barclays PLC	84,572	$274K	0.0%	+91.1%	0.123%
11/15/2024	XTX Topco Ltd	47,672	$154K	0.0%	-77.4%	0.070%
11/15/2024	Jane Street Group LLC	344,173	$1.12M	0.0%	-29.9%	0.502%
11/15/2024	Jacobs Levy Equity Management Inc.	478,440	$1.55M	0.0%	-18.8%	0.698%
Get the Latest News and Ratings for AMLX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Amylyx Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.
11/14/2024	Walleye Capital LLC	670,594	$2.17M	0.0%	+986.5%	0.978%
11/13/2024	Alpha Wave Global LP	669,487	$2.17M	0.7%	N/A	0.977%
11/13/2024	FMR LLC	221,001	$716K	0.0%	+292.0%	0.322%
11/12/2024	Charles Schwab Investment Management Inc.	302,270	$979K	0.0%	-42.1%	0.444%
11/8/2024	Connor Clark & Lunn Investment Management Ltd.	880,745	$2.85M	0.0%	+41.6%	1.294%
10/25/2024	China Universal Asset Management Co. Ltd.	13,094	$42K	0.0%	+63.9%	0.019%
10/25/2024	abrdn plc	1,972,242	$6.39M	0.0%	+1,567.9%	2.900%
10/23/2024	Hennion & Walsh Asset Management Inc.	114,534	$371K	0.0%	-3.7%	0.168%
9/16/2024	Point72 DIFC Ltd	25,953	$49K	0.0%	-47.0%	0.038%
9/16/2024	Cubist Systematic Strategies LLC	166,548	$316K	0.0%	-5.4%	0.245%
9/16/2024	Point72 Asia Singapore Pte. Ltd.	82,042	$156K	0.0%	N/A	0.121%
8/29/2024	Maven Securities LTD	100,000	$190K	0.0%	+300.0%	0.147%
8/16/2024	Algert Global LLC	24,814	$47K	0.0%	N/A	0.036%
8/16/2024	Almitas Capital LLC	1,903,851	$3.62M	1.5%	N/A	2.800%
8/15/2024	Mackenzie Financial Corp	57,923	$110K	0.0%	-20.2%	0.085%
8/15/2024	Millennium Management LLC	1,535,178	$2.92M	0.0%	-38.9%	2.257%
8/15/2024	AQR Capital Management LLC	3,340,943	$6.35M	0.0%	+2,768.0%	4.913%
8/15/2024	Point72 Asia Singapore Pte. Ltd.	82,042	$156K	0.0%	N/A	0.121%
8/14/2024	Squarepoint Ops LLC	272,576	$518K	0.0%	+71.1%	0.401%
8/14/2024	Cubist Systematic Strategies LLC	166,548	$316K	0.0%	-5.4%	0.245%
8/14/2024	Point72 DIFC Ltd	25,953	$49K	0.0%	-47.0%	0.038%
8/12/2024	XTX Topco Ltd	210,612	$400K	0.0%	N/A	0.310%
8/12/2024	Hsbc Holdings PLC	76,261	$150K	0.0%	+57.9%	0.112%
8/9/2024	Renaissance Technologies LLC	811,488	$1.54M	0.0%	+15.2%	1.193%
8/8/2024	American Century Companies Inc.	19,041	$36K	0.0%	-95.0%	0.028%
8/6/2024	Acadian Asset Management LLC	1,211,617	$2.30M	0.0%	N/A	1.782%
8/1/2024	Rhumbline Advisers	28,779	$55K	0.0%	-58.5%	0.042%
7/26/2024	Allspring Global Investments Holdings LLC	28,785	$55K	0.0%	+88.4%	0.042%
7/20/2024	Hennion & Walsh Asset Management Inc.	118,983	$226K	0.0%	+5.4%	0.175%
7/12/2024	SG Americas Securities LLC	55,836	$106K	0.0%	+113.6%	0.082%
7/10/2024	CWM LLC	28,643	$54K	0.0%	+104.2%	0.042%
5/24/2024	Farallon Capital Management LLC	1,150,221	$3.27M	0.0%	N/A	1.691%
5/15/2024	Price T Rowe Associates Inc. MD	970,555	$2.76M	0.0%	+8.5%	1.427%
5/10/2024	Vanguard Group Inc.	5,348,139	$15.19M	0.0%	+1.4%	7.864%
2025 AI Stock Picks: 2 Hidden Gems Under $10/Share (Ad) The AI sector continues to make waves as we move into 2025, and now is a prime opportunity to get involved—without stretching your budget! We’ve just uncovered 2 promising AI stocks trading for under $10/share, and they’re positioned for impressive growth in the coming months. 👉[Click here to get your FREE report delivered instantly!]
5/7/2024	Swiss National Bank	86,600	$246K	0.0%	+8.7%	0.127%
5/7/2024	SG Americas Securities LLC	26,139	$74K	0.0%	-60.4%	0.038%
5/1/2024	Capstone Investment Advisors LLC	80,084	$227K	0.0%	+300.4%	0.118%
4/30/2024	Allspring Global Investments Holdings LLC	15,276	$43K	0.0%	+52,575.9%	0.022%
4/18/2024	Allspring Global Investments Holdings LLC	15,276	$43K	0.0%	+52,575.9%	0.023%
4/17/2024	Hennion & Walsh Asset Management Inc.	112,867	$321K	0.0%	+32.9%	0.167%
3/1/2024	Goldman Sachs Group Inc.	1,256,861	$18.50M	0.0%	+5.9%	1.854%
2/26/2024	Virtu Financial LLC	27,715	$408K	0.0%	N/A	0.041%
2/26/2024	Perceptive Advisors LLC	1,869,125	$27.51M	0.6%	-30.5%	2.758%
2/14/2024	Avidity Partners Management LP	64,501	$949K	0.0%	-96.3%	0.096%
2/14/2024	Nebula Research & Development LLC	57,850	$852K	0.3%	+106.4%	0.086%
2/14/2024	Seven Eight Capital LP	66,801	$983K	0.1%	+11.5%	0.099%
2/14/2024	Sectoral Asset Management Inc.	84,055	$1.24M	0.5%	+14.1%	0.124%
2/13/2024	Stonepine Capital Management LLC	2,500,000	$36.80M	15.9%	-0.6%	3.703%
2/12/2024	Capstone Investment Advisors LLC	20,000	$294K	0.0%	-12.4%	0.030%
2/12/2024	TD Asset Management Inc	115,000	$1.69M	0.0%	N/A	0.170%
2/9/2024	Primecap Management Co. CA	156,900	$2.31M	0.0%	-48.5%	0.232%
2/9/2024	Franklin Resources Inc.	1,325,001	$19.50M	0.0%	+114.4%	1.962%
2/9/2024	Quest Partners LLC	6,035	$89K	0.0%	N/A	0.009%
2/9/2024	Trexquant Investment LP	265,046	$3.90M	0.1%	N/A	0.393%
2/9/2024	Dynamic Technology Lab Private Ltd	31,342	$461K	0.0%	-16.4%	0.046%
2/8/2024	Janney Montgomery Scott LLC	59,111	$870K	0.0%	+38.2%	0.088%
2/7/2024	Jump Financial LLC	13,343	$196K	0.0%	-41.6%	0.020%
2/6/2024	Charles Schwab Investment Management Inc.	387,620	$5.71M	0.0%	+5.9%	0.574%
2/6/2024	Swiss National Bank	79,700	$1.17M	0.0%	+19.8%	0.118%
2/5/2024	Russell Investments Group Ltd.	2,837	$42K	0.0%	-36.7%	0.004%
2/1/2024	New York State Common Retirement Fund	23,754	$350K	0.0%	+11.9%	0.035%
2/1/2024	Handelsbanken Fonder AB	11,900	$175K	0.0%	N/A	0.018%
1/31/2024	abrdn plc	195,493	$2.88M	0.0%	N/A	0.290%
1/31/2024	Federated Hermes Inc.	102,500	$1.51M	0.0%	-68.4%	0.152%
1/30/2024	Zurcher Kantonalbank Zurich Cantonalbank	10,389	$153K	0.0%	+69.4%	0.015%
1/30/2024	Cornercap Investment Counsel Inc.	44,487	$655K	0.1%	-5.6%	0.066%
1/30/2024	Strs Ohio	17,500	$257K	0.0%	N/A	0.026%
1/30/2024	Phocas Financial Corp.	86,073	$1.27M	0.2%	N/A	0.127%
1/24/2024	DekaBank Deutsche Girozentrale	83,000	$1.22M	0.0%	+151.5%	0.123%
1/24/2024	Arizona State Retirement System	11,302	$166K	0.0%	N/A	0.017%
1/24/2024	China Universal Asset Management Co. Ltd.	7,815	$115K	0.0%	+351.7%	0.012%
1/12/2024	Premier Path Wealth Partners LLC	20,265	$298K	0.1%	N/A	0.030%
1/12/2024	SG Americas Securities LLC	66,039	$972K	0.0%	+210.7%	0.098%
12/18/2023	Vanguard Group Inc.	5,050,080	$92.47M	0.0%	+2.5%	7.479%
12/7/2023	Hudson Bay Capital Management LP	682,223	$12.49M	0.1%	+134.5%	1.010%
11/22/2023	Graham Capital Management L.P.	56,241	$1.03M	0.0%	+84.1%	0.083%
11/15/2023	GSA Capital Partners LLP	42,435	$777K	0.1%	+203.0%	0.063%
11/15/2023	Sectoral Asset Management Inc.	73,655	$1.35M	0.3%	-81.0%	0.109%
11/15/2023	Seven Eight Capital LP	59,891	$1.10M	0.1%	N/A	0.089%
11/15/2023	Legacy Advisors LLC	50,000	$916K	0.1%	N/A	0.074%
11/15/2023	Adage Capital Partners GP L.L.C.	1,700,200	$31.13M	0.1%	+121.3%	2.518%
11/15/2023	AXQ Capital LP	10,836	$198K	0.1%	N/A	0.016%
11/15/2023	Axxcess Wealth Management LLC	26,151	$479K	0.0%	N/A	0.039%
11/14/2023	Schonfeld Strategic Advisors LLC	137,523	$2.52M	0.0%	-34.6%	0.204%
URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad) Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight. >> Register for the Workshop Now
11/14/2023	Teza Capital Management LLC	23,594	$432K	0.0%	N/A	0.035%
11/14/2023	Avidity Partners Management LP	1,756,940	$32.17M	1.3%	+94.9%	2.602%
11/14/2023	Qube Research & Technologies Ltd	162,710	$2.98M	0.0%	+31.0%	0.241%
11/14/2023	Stonepine Capital Management LLC	2,515,868	$46.07M	15.3%	+124.4%	3.726%
11/14/2023	Primecap Management Co. CA	304,900	$5.58M	0.0%	N/A	0.452%
11/14/2023	Profund Advisors LLC	19,368	$355K	0.0%	+40.2%	0.029%
11/13/2023	Millrace Asset Group Inc.	19,496	$357K	0.4%	N/A	0.029%
11/13/2023	Connor Clark & Lunn Investment Management Ltd.	124,455	$2.28M	0.0%	N/A	0.184%
11/13/2023	Algert Global LLC	161,405	$2.96M	0.1%	N/A	0.239%
11/13/2023	Federated Hermes Inc.	324,260	$5.94M	0.0%	-78.8%	0.480%

(Data available from 1/1/2016 forward)

AMLX Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of AMLX shares?: During the previous two years, 130 institutional investors and hedge funds held shares of Amylyx Pharmaceuticals. The most heavily invested institutionals were Point72 Asset Management L.P. ($78.63M), Marshall Wace LLP ($42.71M), Pictet Asset Management SA ($42.07M), Stonepine Capital Management LLC ($36.80M), Rock Springs Capital Management LP ($33.32M), Adage Capital Partners GP L.L.C. ($31.13M), and Perceptive Advisors LLC ($27.51M).Learn more on AMLX's institutional investors.
What percentage of Amylyx Pharmaceuticals stock is owned by institutional investors?: 95.84% of Amylyx Pharmaceuticals stock is owned by institutional investors. Learn more on AMLX's institutional investor holdings.
Which institutional investors have been buying Amylyx Pharmaceuticals stock?: Of the 105 institutional investors that purchased Amylyx Pharmaceuticals stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: AQR Capital Management LLC ($3.22M), abrdn plc ($2.05M), Almitas Capital LLC ($1.90M), Point72 Asset Management L.P. ($1.66M), Stonepine Capital Management LLC ($1.39M), Acadian Asset Management LLC ($1.21M), and Farallon Capital Management LLC ($1.15M).

How much institutional buying is happening at Amylyx Pharmaceuticals?: Institutional investors have bought a total of 26,222,920 shares in the last 24 months. This purchase volume represents approximately $359.08M in transactions.
Which Amylyx Pharmaceuticals major shareholders have been selling company stock?: Of the 41 institutional investors that sold Amylyx Pharmaceuticals stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Perceptive Advisors LLC ($1.98M), Avidity Partners Management LP ($1.69M), Federated Hermes Inc. ($1.43M), Millennium Management LLC ($976.28K), Allspring Global Investments Holdings LLC ($528.07K), Sectoral Asset Management Inc. ($361.11K), and American Century Companies Inc. ($359.76K).
How much institutional selling is happening at Amylyx Pharmaceuticals?: Institutional investors have sold a total of 9,125,312 shares in the last 24 months. This volume of shares sold represents approximately $132.88M in transactions.

Related Companies

This page (NASDAQ:AMLX) was last updated on 12/21/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Amylyx Pharmaceuticals (AMLX) Institutional Ownership

AMLX Institutional Buying and Selling by Quarter

Amylyx Pharmaceuticals Major Shareholders & Ownership History

AMLX Institutional Ownership - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Amylyx Pharmaceuticals (AMLX) Institutional Ownership

Institutional Ownership Changes (13F Filings) for Amylyx Pharmaceuticals (NASDAQ:AMLX)

AMLX Institutional Buying and Selling by Quarter

Amylyx Pharmaceuticals Major Shareholders & Ownership History

AMLX Institutional Ownership - Frequently Asked Questions

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools